Jak Stat Pathway Inhibition: A New Horizon in the Therapy of Reumatoide Arthritis by Dynamicom Education Srl

Jak Stat Pathway Inhibition: A New Horizon in the Therapy of Reumatoide Arthritis is organized by Dynamicom Education Srl and will be held from Nov 15, 2018 - Nov 14, 2019. This Conference has been approved for a maximum of 5.0 ECM credits.

Program:
• Physiopathology of Rheumatoid Arthritis - EG Favalli
• The pathway of JAK Stat and Jak inhibitors - L. Sinigaglia
• Inhibitors of JAK: efficacy profile - M. Biggioggero
• Inhibitors of JAK: safety profile - L. Sinigaglia
• Preliminary data on JAK inhibitors: data from Real Life - A. Becciolini
• Inhibitors of JAK: guidelines - N. Ughi
• Future perspectives in the inhibition of the JAK-STAT pathway - M. Gerosa
• Future perspectives in the inhibition of the JAK-STAT pathway: spondyloarthritis - A. Marchesoni
• Clinical management of JAK inhibitors - I. Scotti

Educational goal:
3 - Clinical documentation. Clinical journeys - diagnostic and rehabilitation assistance, care profiles - care profiles

Additional details will Arthritis is as soon as they are available.